FXYD3 and lung cancer: With the aforementioned findings taken into consideration, we conducted the present study with the aims of elucidating the regulatory role of EV‐let‐7i in lung cancer with the involvement of KDM3A/DCLK1/FXYD3 for finding a novel target for lung cancer treatment.